查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279917

2023-2030年全球仿制药市场规模研究与预测，按类型、按应用、按产品、按给药途径、按分销渠道和区域分析

Global Generic Pharmaceuticals Market Size study & Forecast, by Type, by Application, by Product, By Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2022年全球仿制药市场价值约为3617亿美元，预计在2022-2029年预测期内将以超过8.3%的健康增长率增长。仿制药是指在剂量、安全性、强度、给药途径、质量和预期用途方面与品牌药相同或生物等效的药物。仿制药是在原品牌药物的专利权过期后生产的。这使得其他制药公司能够以较低的成本生产和销售相同的药物，因为他们不需要投资于创造新药所需的昂贵的研究和开发。仿制药市场正在扩大，因为各种因素，如不断上升的、不断增加的ANDA批准和仿制产品的推出以及政府促进仿制药使用的倡议。

ANDA批准数量的上升和仿制药产品的推出是市场增长的原因。根据美国FDA的仿制药年度报告，ANDA批准的数量从2020年的948个增加到2021年的776个。此外，来自同一来源的报告称，到2021年底，总体上有100个ANDA获得批准。政府已经实施了一些计划，为重要的仿制药企业提供了各种机会，以减少药品的支出。作为一个例子，通过在2021年使用仿制药，美国政府节省了3.73亿美元的医药费用。根据AAM的《2021年非专利药和生物仿制药获取和节约报告》，91%的处方是用非专利药来填补的，这占处方药成本的18.2%。此外，疾病负担的增加和老年人口的上升正在为市场创造有利可图的增长。然而，非专利药的实际价格缺乏透明度，阻碍了市场的增长。

全球仿制药市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。北美在收入方面占主导地位，由于存在关键的市场增长和该地区日益增长的疾病流行率，加上这些越来越多的有利的政府倡议，以及不断增加的产品推出和对仿制药的需求，正在推动该地区的市场增长。而亚太地区在预测期内预计将以最高的复合年增长率增长，这是因为诸如老年病和目标人群的上升、产品开发合作数量的增加、主要参与者的地理扩张以及政府和非营利组织对市场空间的积极参与等因素。

该研究的目的是确定近年来不同领域和国家的市场规模，并预测未来几年的价值。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2020-2030年全球和细分市场的估计和预测
    • 2020-2030年，按地区分類的仿制药市场
    • 2020-2030年，按类型分類的仿制药市场
    • 2020-2030年，按应用分類的仿制药市场
    • 2020-2030年，按产品分類的仿制药市场
    • 2020-2030年，按给药途径分類的仿制药市场
    • 2020-2030年，按分销渠道分類的仿制药市场
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球仿制药市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 行业演变
    • 研究的范围
  • 研究考虑的年份
  • 货币兑换率

第三章：全球仿制药市场动态

  • 仿制药市场影响分析（2020-2030年）
    • 市场驱动力
      • 越来越多的ANDA批准和非专利产品的推出
      • 政府采取措施促进仿制药的使用
    • 市场挑战
      • 仿制药的高成本
      • 定价问题
    • 市场机会
      • 不断增加的疾病负担
      • 老年人口不断增加

第四章：全球仿制药市场行业分析

  • 波特的五力模型
    • 供应商的讨价还价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力影响分析
  • PEST分析
    • 政治
    • 经济
    • 社会
    • 技术
    • 环境
    • 法律问题
  • 最佳投资机会
  • 最佳策略
  • COVID-19影响分析
  • 颠覆性趋势
  • 行业专家的观点
  • 分析师建议与结论

第五章：全球仿制药市场，按类型划分

  • 市场简介
  • 按类型分類的全球仿制药市场，性能-潜力分析
  • 2020-2030年全球仿制药市场按类型的估计和预测
  • 仿制药市场，細項分析
    • 简单仿制药
    • 特殊仿制药
    • 生物仿制药

第六章：全球仿制药市场，按应用分类

  • 市场简介
  • 按应用分类的全球仿制药市场，表现 - 潜力分析
  • 2020-2030年全球仿制药市场按应用的估计和预测
  • 仿制药市场，細項分析
    • 中枢神经系统疾病
    • 呼吸系统疾病
    • 激素及相关疾病
    • 胃肠道疾病
    • 心血管疾病
    • 传染性疾病
    • 其他疾病

第7章 ：全球仿制药市场，按产品分类

  • 市场简介
  • 按产品分類的全球仿制药市场，表现 - 潜力分析
  • 2020-2030年全球仿制药市场按产品的估计和预测
  • 仿制药市场，次级細項分析
    • 小分子药物
    • 大分子化合物

第8章：按给药途径分類的全球仿制药市场

  • 市场简介
  • 按给药途径分類的全球仿制药市场，表现 - 潜力分析
  • 2020-2030年按给药途径分類的全球仿制药市场估计和预测
  • 仿制药市场，次级細項分析
    • 口服
    • 注射式
    • 吸入式
    • 其他途径

第九章：全球仿制药市场，按分销渠道划分

  • 市场简介
  • 按分销渠道分類的全球仿制药市场，表现 - 潜力分析
  • 2020-2030年全球仿制药市场按分销渠道的估计和预测
  • 仿制药市场，次级细分市场分析
    • 网上药店
    • 零售药店
    • 医院药店

第十章：全球仿制药市场，区域分析

  • 最领先的国家
  • 新兴国家
  • 仿制药市场，区域市场简介
  • 北美洲
    • 美国
      • 2020-2030年类型细分的估计和预测
      • 2020-2030年应用细分的估计和预测
      • 2020-2030年，产品细分的估计和预测
      • 2020-2030年给药途径分类估计和预测 10.4.1.5.2020-2030年分销渠道细分的估计和预测
    • 加拿大
  • 欧洲仿制药市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区仿制药市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲仿制药市场简况
    • 巴西
    • 墨西哥
  • 世界其他地区

第十一章 ：竞争情报

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司3
  • 顶级市场战略
  • 公司简介
    • Teva Pharmaceutical Industries Ltd.
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 最近的发展情况
    • Viatris Inc.
    • Novartis AG
    • Sun Pharmaceutical Industries Ltd.
    • LUPIN
    • AbbVie Inc. (Allergan)
    • AstraZeneca
    • Sawai Pharmaceutical Co., Ltd.
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy's Laboratories Ltd.

第十二章 ：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Generic Pharmaceuticals Market is valued at approximately USD 361.7 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2022-2029. Generic pharmaceuticals are medications that are identical, or bioequivalent, to brand-name drugs in terms of dosage, safety, strength, route of administration, quality, and intended use. Generic drugs are produced after the patent for the original brand-name drug has expired. This allows other pharmaceutical companies to manufacture and sell the same medication at a lower cost because they do not need to invest in the costly research and development that is required to create a new drug. The Generic Pharmaceuticals market is expanding because of factors such as rising, increasing ANDA approval and generic product launches and government initiatives to promote the usage of generics.

The rise in the number of ANDA approvals and generic medication product launches accounts for the market growth. according to the U.S. FDA's Generic Drugs Annual report, the number of ANDA approvals increased from 948 in 2020 to 776 in 2021. Additionally, from the same source, it was reported that 100 ANDAs had been approved overall by the end of 2021. Governments have implemented programs that offer various opportunities for significant generic drug players to cut back on expenditure on pharmaceuticals. As an illustration, by using generic medications in 2021, the U.S. government saved USD 373 million on pharmaceutical costs. According to the AAM Generic Drug & Biosimilars Access & Savings Report 2021, 91% of prescriptions are filled with generic medication, which represents 18.2% of prescription drug costs. In addition, the increasing Disease Burden and Rising Geriatric Population are creating lucrative growth in the market. However, a lack of transparency about the actual price of generic drugs hampers the market growth.

The key regions considered for the Global Generic Pharmaceuticals Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of key market growth and the region's increasing disease prevalence, along with these increasing number of favorable government initiatives coupled with the rising number of product launches and demand for a generic drug is driving the market growth in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • LUPIN
  • AbbVie Inc. (Allergan)
  • AstraZeneca
  • Sawai Pharmaceutical Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd.

Recent Developments in the Market:

  • In January 2022, the Mark Cuban Cost Plus Drugs Company (MCCPDC) announced the launch of an online pharmacy. The pharmacy would offer around more than 100 generic drugs at a low cost to patients.

Global Generic Pharmaceuticals Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Type, Application, Product, Application, Route of Administration, Distribution Channel, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Simple Generics
  • Specialty Generics
  • Biosimilars

By Application:

  • Central Nervous System Disorders
  • Respiratory Diseases
  • Hormones & Related Diseases
  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By Product:

  • Small Molecule
  • Large Molecule

By Route of Administration:

  • Oral
  • Injectable
  • Inhalable
  • Others

Distribution Channel:

  • Online Pharmacies
  • Hospitals Pharmacies
  • Retail Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
    • 1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Generic Pharmaceuticals Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Generic Pharmaceuticals Market Dynamics

  • 3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing ANDA approval and Generic Product Launches
      • 3.1.1.2. Government initiatives to promote usage of generics
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Generic Pharmaceuticals
      • 3.1.2.2. Pricing issues
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Disease Burden
      • 3.1.3.2. Rising Geriatric Population

Chapter 4. Global Generic Pharmaceuticals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Generic Pharmaceuticals Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
  • 5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 5.4.1. Simple Generics
    • 5.4.2. Specialty Generics
    • 5.4.3. Biosimilars

Chapter 6. Global Generic Pharmaceuticals Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
  • 6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 6.4.1. Central Nervous System Disorders
    • 6.4.2. Respiratory Diseases
    • 6.4.3. Hormones & Related Diseases
    • 6.4.4. Gastrointestinal Diseases
    • 6.4.5. Cardiovascular Diseases
    • 6.4.6. Infectious Diseases
    • 6.4.7. Others

Chapter 7. Global Generic Pharmaceuticals Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
  • 7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 7.4.1. Small Molecule
    • 7.4.2. Large Molecule

Chapter 8. Global Generic Pharmaceuticals Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injectable
    • 8.4.3. Inhalable
    • 8.4.4. Others

Chapter 9. Global Generic Pharmaceuticals Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
  • 9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
    • 9.4.1. Online Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Hospital Pharmacies

Chapter 10. Global Generic Pharmaceuticals Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
  • 10.4. North America Generic Pharmaceuticals Market
    • 10.4.1. U.S. Generic Pharmaceuticals Market
      • 10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Generic Pharmaceuticals Market
  • 10.5. Europe Generic Pharmaceuticals Market Snapshot
    • 10.5.1. U.K. Generic Pharmaceuticals Market
    • 10.5.2. Germany Generic Pharmaceuticals Market
    • 10.5.3. France Generic Pharmaceuticals Market
    • 10.5.4. Spain Generic Pharmaceuticals Market
    • 10.5.5. Italy Generic Pharmaceuticals Market
    • 10.5.6. Rest of Europe Generic Pharmaceuticals Market
  • 10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
    • 10.6.1. China Generic Pharmaceuticals Market
    • 10.6.2. India Generic Pharmaceuticals Market
    • 10.6.3. Japan Generic Pharmaceuticals Market
    • 10.6.4. Australia Generic Pharmaceuticals Market
    • 10.6.5. South Korea Generic Pharmaceuticals Market
    • 10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
  • 10.7. Latin America Generic Pharmaceuticals Market Snapshot
    • 10.7.1. Brazil Generic Pharmaceuticals Market
    • 10.7.2. Mexico Generic Pharmaceuticals Market
  • 10.8. Rest of The World Generic Pharmaceuticals Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Teva Pharmaceutical Industries Ltd.
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. Viatris Inc.
    • 11.3.3. Novartis AG
    • 11.3.4. Sun Pharmaceutical Industries Ltd.
    • 11.3.5. LUPIN
    • 11.3.6. AbbVie Inc. (Allergan)
    • 11.3.7. AstraZeneca
    • 11.3.8. Sawai Pharmaceutical Co., Ltd.
    • 11.3.9. Hikma Pharmaceuticals PLC
    • 11.3.10. Dr. Reddy's Laboratories Ltd.

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Generic Pharmaceuticals Market, report scope
  • TABLE 2. Global Generic Pharmaceuticals Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Generic Pharmaceuticals Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Generic Pharmaceuticals Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Generic Pharmaceuticals Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 6. Global Generic Pharmaceuticals Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 7. Global Generic Pharmaceuticals Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 8. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. Saudi Arabia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70. South Africa Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. RoMEA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 72. List of secondary sources, used in the study of global Generic Pharmaceuticals Market
  • TABLE 73. List of primary sources, used in the study of global Generic Pharmaceuticals Market
  • TABLE 74. Years considered for the study
  • TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Generic Pharmaceuticals Market, research methodology
  • FIG 2. Global Generic Pharmaceuticals Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Generic Pharmaceuticals Market, key trends 2022
  • FIG 5. Global Generic Pharmaceuticals Market, growth prospects 2023-2030
  • FIG 6. Global Generic Pharmaceuticals Market, porters 5 force model
  • FIG 7. Global Generic Pharmaceuticals Market, pest analysis
  • FIG 8. Global Generic Pharmaceuticals Market, value chain analysis
  • FIG 9. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Generic Pharmaceuticals Market, regional snapshot 2020 & 2030
  • FIG 15. North America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable